Literature DB >> 18691551

DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression.

Ben J Shields1, Christine Hauser, Patricia E Bukczynska, Naomi W Court, Tony Tiganis.   

Abstract

Here we report that T cell protein tyrosine phosphatase (TCPTP)-dependent and -independent pathways attenuate the JAK and Src protein tyrosine kinases (PTKs) and STAT3 phosphorylation to suppress cyclin D1 expression and S phase progression in response to DNA replication stress. Cells that lack TCPTP fail to suppress JAK1, Src, and STAT3, allowing for sustained cyclin D1 levels and progression through S phase despite continued replication stress. Cells that bypass the checkpoint undergo aberrant mitoses with lagging chromosomes that stain for the DNA damage marker gamma H2AX. Therefore, inactivating JAK, Src, and STAT3 signaling pathways in response to DNA replication stress may be essential for the suppression of S phase progression and the maintenance of genomic stability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691551     DOI: 10.1016/j.ccr.2008.06.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  27 in total

1.  Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance.

Authors:  Kim Loh; Atsushi Fukushima; Xinmei Zhang; Sandra Galic; Dana Briggs; Pablo J Enriori; Stephanie Simonds; Florian Wiede; Alexander Reichenbach; Christine Hauser; Natalie A Sims; Kendra K Bence; Sheng Zhang; Zhong-Yin Zhang; Barbara B Kahn; Benjamin G Neel; Zane B Andrews; Michael A Cowley; Tony Tiganis
Journal:  Cell Metab       Date:  2011-10-13       Impact factor: 27.287

2.  Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia.

Authors:  Maria Kleppe; Idoya Lahortiga; Tiama El Chaar; Kim De Keersmaecker; Nicole Mentens; Carlos Graux; Katrien Van Roosbroeck; Adolfo A Ferrando; Anton W Langerak; Jules P P Meijerink; François Sigaux; Torsten Haferlach; Iwona Wlodarska; Peter Vandenberghe; Jean Soulier; Jan Cools
Journal:  Nat Genet       Date:  2010-05-16       Impact factor: 38.330

Review 3.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

4.  STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation.

Authors:  Siva Koganti; Joyce Hui-Yuen; Shane McAllister; Benjamin Gardner; Friedrich Grasser; Umaimainthan Palendira; Stuart G Tangye; Alexandra F Freeman; Sumita Bhaduri-McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

5.  C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression.

Authors:  Snehalata A Pawar; Tapasree Roy Sarkar; Kuppusamy Balamurugan; Shikha Sharan; Jun Wang; Youhong Zhang; Steven F Dowdy; A-Mei Huang; Esta Sterneck
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

6.  TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers.

Authors:  Benjamin J Shields; Florian Wiede; Esteban N Gurzov; Kenneth Wee; Christine Hauser; Hong-Jian Zhu; Timothy J Molloy; Sandra A O'Toole; Roger J Daly; Robert L Sutherland; Christina A Mitchell; Catriona A McLean; Tony Tiganis
Journal:  Mol Cell Biol       Date:  2012-11-19       Impact factor: 4.272

7.  Protein tyrosine phosphatases, TC-PTP, SHP1, and SHP2, cooperate in rapid dephosphorylation of Stat3 in keratinocytes following UVB irradiation.

Authors:  Dae Joon Kim; Michel L Tremblay; John Digiovanni
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

8.  Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?

Authors:  Andrew Jarnicki; Tracy Putoczki; Matthias Ernst
Journal:  Cell Div       Date:  2010-05-17       Impact factor: 5.130

9.  T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis.

Authors:  Atsushi Fukushima; Kim Loh; Sandra Galic; Barbara Fam; Ben Shields; Florian Wiede; Michel L Tremblay; Matthew J Watt; Sofianos Andrikopoulos; Tony Tiganis
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

10.  Activation of the prereplication complex is blocked by mimosine through reactive oxygen species-activated ataxia telangiectasia mutated (ATM) protein without DNA damage.

Authors:  Shoichi Kubota; Yasunori Fukumoto; Kenichi Ishibashi; Shuhei Soeda; Sho Kubota; Ryuzaburo Yuki; Yuji Nakayama; Kazumasa Aoyama; Noritaka Yamaguchi; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2014-01-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.